ASKA Pharmaceutical Holdings (4886) · InitiativeRestatedLatest Management planning (2026-03-23): "Advanced"
Development and Commercialization of Animal Welfare Products
First written in FY2022. 2 of 4 entries say "Advanced", first in FY2023. Latest entry: 2026-03-23.
4entries
5years
1from disclosures
How it moved
Same theme, other companies
Development of New Products for the Veterinary MarketA theme 6 companies write about · 0 as a headwind · 7 as a tailwind
1 other company's latest entry also says "Advanced".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
- 2026-03-23AdvancedManagement planning
「We will expand products for livestock and companion animals, focusing on areas in which we have strengths, including reproduction and endocrinology.」
The animal health business was specified in terms of its target areas and expansion of products for livestock and companion animals. - FY2024RestatedAnnual report
「また動物用医薬品・飼料等を販売するあすかアニマルヘルスにおいては、アニマルウェルフェアに貢献できる製品の開発・発売を継続して進めており、成長が期待されるコンパニオンアニマル向けの製品の一層の浸透を進めてまいります。」
アニマルウェルフェア製品の開発・発売と、コンパニオンアニマル向け製品の浸透を継続する方針を再確認している。 - FY2023AdvancedAnnual report
「猫・抗甲状腺剤チロブロックに加え、本邦に多い小型犬にも対応できるよう低用量規格もラインナップした犬・副腎皮質機能亢進症治療剤トリロスタン錠「あすか」を2022年11月に発売しました。」
アニマルウェルフェア関連製品について、犬用トリロスタン錠「あすか」の低用量規格を2022年11月に発売したという具体的進展を記載している。 - FY2022First statedAnnual report
「We will continue developing and launching products that can contribute to animal welfare.」
The company states that it will develop and launch products contributing to animal welfare in the animal pharmaceuticals business.